An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

November marks diabetes awareness month, a crucial time to focus on prevention, management, and lifestyle adjustments for the ...

With World Diabetes Day approaching, health officials stress the importance of diabetes management and introduce innovative ...

The Mediterranean diet prioritizes healthy fats, whole grains, fruits, and veggies. Our editor gave it a try to see if the ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

More patients come forward with stories about the pains they've suffered since beginning Ozempic, joining a growing number of ...

Novo Nordisk (NVO) is aware of 10 deaths and 100 hospitalizations of people that took copycat versions of its popular drugs ...

Novo Nordisk's (NVO) semaglutide, marketed as Wegovy for obesity, shows promise in reducing joint disease symptoms in ...

The Danish drugmaker plans to introduce a combination drug, CagriSema, that could result in 25% weight loss — higher than ...